In particular, despite there being no evidence to suggest that Black women with breast cancer have lower rates of BRCA1/2 pathogenic variants than White women,3 studies from several states have found that Black women with breast cancer have lower rates of indicated testing than White women.4, 5, 6. This evidence concerns the gene BRCA1 and breast cancer.